White Papers + Downloads

The Richard Rose Report
The HempNut Book
The HempNut Cookbook
The HempNut Book

This is the original version of the 2nd edition cookbook except without the recipes, but including a Glossary with 48 terms and full Bibliography with 514 references. It was what was sent to the publisher before it was edited to fit into 192 pages printed. I’m offering this version free as it’s a great reference book, with hempseed history, nutritional info, and more. 80 pages, PDF. FREE.

Cost of Goods Sold Analysis Model

A Cost of Goods Sold Analysis Model by Richard Rose. Excel file. For calculating total direct cost of goods of a product, including packaging, shipping, box, gross profit margins, suggested retail prices, etc. The values are useless to you, as the formulas are where the magic happens. Just add your products and data. FREE, $999 value.

Cash Flow Analysis Model

A Cash Flow Analysis Model by Richard Rose. Excel file. For forecasting cash flow for three years, sales less cost of goods sold less selling expenses less operating expenses shows you gross profit, net profit and net cash, and percentages. The values are useless to you, as the formulas are where the magic happens. Just add your products and data. FREE, $999 value.

The HempNut Cookbook (both editions)
The HempNut Cookbook (both editions)

Here’s a free download of my The HempNut Cookbookboth editions combined. 200 recipes, 180 pages, tons of original historical and nutritional information. Perhaps the first consumer mention of CBD (2000).

FDA Report on CBD to Congress
FDA Report on CBD to Congress

Report to the U.S. House Committee on Appropriations and the U.S. Senate Committee on Appropriations on Cannabidiol (CBD) by U.S. Food and Drug Administration.

On December 20, 2019, the Further Consolidated Appropriations Act, 2020 (P.L. 116-94), was enacted into law, which provided FDA with appropriations under Division B, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Act, 2020, for the fiscal year ending September 30, 2020. The accompanying Joint Explanatory Statement directed the Food and Drug Administration (FDA or the Agency) to report on Cannabidiol (CBD):
“Within 60 days of enactment of this Act, the FDA shall provide the Committees with a report regarding the agency’s progress toward obtaining and analyzing data to help determine a policy of enforcement discretion and the process in which CBD meeting the definition of hemp will be evaluated for use in products.” In response to this directive, FDA prepared the following report. 18 pages.


























































Leave Your Reply